Acta Diabetologica

, Volume 52, Issue 1, pp 167–174

Levels of adiponectin and leptin at onset of type 1 diabetes have changed over time in children and adolescents

  • Narges Safai
  • Stefanie Eising
  • David Michael Hougaard
  • Henrik Bindesbøl Mortensen
  • Kristin Skogstrand
  • Flemming Pociot
  • Jesper Johannesen
  • Jannet Svensson
Original Article

Abstract

Adiponectin and leptin are proteins secreted by the adipose tissue and have an influence on insulin sensitivity and on inflammatory markers. Altered levels could play a part in the pathogenesis of type 1 diabetes mellitus. We determined adiponectin and leptin levels over a nine-year period in children with type 1 diabetes mellitus (T1D) in relation to the increasing incidence of T1D, and studied the impact of patient status, age, gender and body mass index (BMI). Data were derived from a population-based registry of diabetic children (DanDiabKids) from 1997 to 2005. Children with newly diagnosed T1D (n = 482) were included, and healthy siblings (n = 479) were chosen as a control group. Leptin levels were significantly higher in recent years (in both patients and siblings), whereas for adiponectin, the levels were lower in recent years in the patient group. Leptin levels were lower in children with T1D (RR 0.74, p = 0.003) and in males (RR 0.52, p < 0.001) and increasing with age in both groups. For adiponectin, there was a negative association between level and age in patients. Both adipokines showed a significant correlation with BMI and lower levels in children with blood samples taken within the first 2 days after initiation of insulin treatment. There has been a change in leptin and adiponectin levels in children with or without T1D from 1997 to 2005. This is not explained by changes in BMI and may reflect changes in other factors like diet or physical activity.

Keywords

Diabetes in childhood Pathophysiology Adipose tissue biology Adipocytokines 

References

  1. 1.
    Onkamo P, Vaananen S, Karvonen M, Tuomilehto J (1999) Worldwide increase in incidence of Type I diabetes—the analysis of the data on published incidence trends. Diabetologia 42(12):1395–1403. doi:10.1007/s001250051309 PubMedCrossRefGoogle Scholar
  2. 2.
    Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257(1):79–83PubMedCrossRefGoogle Scholar
  3. 3.
    Lihn AS, Pedersen SB, Richelsen B (2005) Adiponectin: action, regulation and association to insulin sensitivity. Obes Rev 6(1):13–21. doi:10.1111/j.1467-789X.2005.00159.x PubMedCrossRefGoogle Scholar
  4. 4.
    Wolf AM, Wolf D, Rumpold H, Enrich B, Tilg H (2004) Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun 323(2):630–635. doi:10.1016/j.bbrc.2004.08.145 PubMedCrossRefGoogle Scholar
  5. 5.
    Shimada K, Miyazaki T, Daida H (2004) Adiponectin and atherosclerotic disease. Clin Chim Acta 344(1–2):1–12. doi:10.1016/j.cccn.2004.02.020 PubMedCrossRefGoogle Scholar
  6. 6.
    Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S (2005) Adipokines: molecular links between obesity and atherosclerosis. Am J Physiol Heart Circ Physiol 288(5):H2031–H2041. doi:10.1152/ajpheart.01058.2004 PubMedCrossRefGoogle Scholar
  7. 7.
    Koerner A, Kratzsch J, Kiess W (2005) Adipocytokines: leptin–the classical, resistin–the controversical, adiponectin–the promising, and more to come. Best Pract Res Clin Endocrinol Metab 19(4):525–546. doi:10.1016/j.beem.2005.07.008 PubMedCrossRefGoogle Scholar
  8. 8.
    Huerta MG (2006) Adiponectin and leptin: potential tools in the differential diagnosis of pediatric diabetes? Rev Endocr Metab Disord 7(3):187–196. doi:10.1007/s11154-006-9017-x PubMedCrossRefGoogle Scholar
  9. 9.
    Fernandez-Riejos P, Najib S, Santos-Alvarez J, Martin-Romero C, Perez-Perez A, Gonzalez-Yanes C, Sanchez-Margalet V (2010) Role of leptin in the activation of immune cells. Mediators Inflamm 2010:568343. doi:10.1155/2010/568343 PubMedCentralPubMedCrossRefGoogle Scholar
  10. 10.
    Svensson J, Eising S, Hougaard DM, Mortensen HB, Skogstrand K, Simonsen LB, Carstensen B, Nilsson A, Lernmark A, Pociot F, Johannesen J (2012) Few differences in cytokines between patients newly diagnosed with type 1 diabetes and their healthy siblings. Hum Immunol 73(11):1116–1126. doi:10.1016/j.humimm.2012.07.337 PubMedCrossRefGoogle Scholar
  11. 11.
    Brorsson C, Vaziri-Sani F, Bergholdt R, Eising S, Nilsson A, Svensson J, Lernmark A, Pociot F (2011) Correlations between islet autoantibody specificity and the SLC30A8 genotype with HLA-DQB1 and metabolic control in new onset type 1 diabetes. Autoimmunity 44(2):107–114. doi:10.3109/08916934.2010.509120 PubMedCrossRefGoogle Scholar
  12. 12.
    Nysom K, Molgaard C, Michaelsen KF, Hutchings B, Andersen E (2002) Body mass index. Reference values for 0–45-year-old Danes. Ugeskr Laeger 164(49):5773–5777PubMedGoogle Scholar
  13. 13.
    Skogstrand K, Thorsen P, Norgaard-Pedersen B, Schendel DE, Sorensen LC, Hougaard DM (2005) Simultaneous measurement of 25 inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay with xMAP technology. Clin Chem 51(10):1854–1866. doi:10.1373/clinchem.2005.052241 PubMedCrossRefGoogle Scholar
  14. 14.
    Nielsen LB, Vaziri-Sani F, Porksen S, Andersen ML, Svensson J, Bergholdt R, Pociot F, Hougaard P, de Beaufort C, Castano L, Mortensen HB, Lernmark A, Hansen L (2011) Relationship between ZnT8Ab, the SLC30A8 gene and disease progression in children with newly diagnosed type 1 diabetes. Autoimmunity 44(8):616–623. doi:10.3109/08916934.2011.576724 PubMedCrossRefGoogle Scholar
  15. 15.
    Rolland-Cachera MF, Castetbon K, Arnault N, Bellisle F, Romano MC, Lehingue Y, Frelut ML, Hercberg S (2002) Body mass index in 7–9-y-old French children: frequency of obesity, overweight and thinness. Int J Obes Relat Metab Disord 26(12):1610–1616. doi:10.1038/sj.ijo.0802146 PubMedCrossRefGoogle Scholar
  16. 16.
    Lobstein TJ, James WP, Cole TJ (2003) Increasing levels of excess weight among children in England. Int J Obes Relat Metab Disord 27(9):1136–1138. doi:10.1038/sj.ijo.0802324 PubMedCrossRefGoogle Scholar
  17. 17.
    Reilly JJ, Dorosty AR (1999) Epidemic of obesity in UK children. Lancet 354(9193):1874–1875. doi:10.1016/S0140-6736(99)04555-9 PubMedCrossRefGoogle Scholar
  18. 18.
    Zimmermann MB, Gubeli C, Puntener C, Molinari L (2004) Detection of overweight and obesity in a national sample of 6–12-y-old Swiss children: accuracy and validity of reference values for body mass index from the US Centers for Disease Control and Prevention and the International Obesity Task Force. Am J Clin Nutr 79(5):838–843PubMedGoogle Scholar
  19. 19.
    Ogden CL, Flegal KM, Carroll MD, Johnson CL (2002) Prevalence and trends in overweight among US children and adolescents, 1999–2000. JAMA 288(14):1728–1732PubMedCrossRefGoogle Scholar
  20. 20.
    Ogden CL, Carroll MD, Kit BK, Flegal KM (2012) Prevalence of obesity and trends in body mass index among US children and adolescents, 1999–2010. JAMA 307(5):483–490. doi:10.1001/jama.2012.40 PubMedCrossRefGoogle Scholar
  21. 21.
    Celi F, Bini V, Papi F, Santilli E, Castellani MS, Ferretti A, Mencacci M, Berioli MG, De Giorgi G, Falorni A (2006) Circulating adipocytokines in non-diabetic and Type 1 diabetic children: relationship to insulin therapy, glycaemic control and pubertal development. Diabet Med 23(6):660–665. doi:10.1111/j.1464-5491.2006.01823.x PubMedCrossRefGoogle Scholar
  22. 22.
    Morales A, Wasserfall C, Brusko T, Carter C, Schatz D, Silverstein J, Ellis T, Atkinson M (2004) Adiponectin and leptin concentrations may aid in discriminating disease forms in children and adolescents with type 1 and type 2 diabetes. Diabetes Care 27(8):2010–2014PubMedCrossRefGoogle Scholar
  23. 23.
    Ahmed ML, Ong KK, Watts AP, Morrell DJ, Preece MA, Dunger DB (2001) Elevated leptin levels are associated with excess gains in fat mass in girls, but not boys, with type 1 diabetes: longitudinal study during adolescence. J Clin Endocrinol Metab 86(3):1188–1193PubMedCrossRefGoogle Scholar
  24. 24.
    Galler A, Gelbrich G, Kratzsch J, Noack N, Kapellen T, Kiess W (2007) Elevated serum levels of adiponectin in children, adolescents and young adults with type 1 diabetes and the impact of age, gender, body mass index and metabolic control: a longitudinal study. Eur J Endocrinol 157(4):481–489. doi:10.1530/EJE-07-0250 PubMedCrossRefGoogle Scholar
  25. 25.
    Larsen LM, Hertel NT, Molgaard C, Christensen R, Husby S, Jarbol DE (2012) Prevalence of overweight and obesity in Danish preschool children over a 10-year period: a study of two birth cohorts in general practice. Acta Paediatr 101(2):201–207. doi:10.1111/j.1651-2227.2011.02551.x PubMedCrossRefGoogle Scholar
  26. 26.
    Salbe AD, Nicolson M, Ravussin E (1997) Total energy expenditure and the level of physical activity correlate with plasma leptin concentrations in five-year-old children. J Clin Investig 99(4):592–595. doi:10.1172/JCI119200 PubMedCentralPubMedCrossRefGoogle Scholar
  27. 27.
    Sartorius T, Heni M, Tschritter O, Preissl H, Hopp S, Fritsche A, Lievertz PS, Gertler A, Berthou F, Taouis M, Staiger H, Haring HU, Hennige AM (2012) Leptin affects insulin action in astrocytes and impairs insulin-mediated physical activity. Cell Physiol Biochem 30(1):238–246. doi:10.1159/000339060 PubMedCrossRefGoogle Scholar
  28. 28.
    Tjonna AE, Stolen TO, Bye A, Volden M, Slordahl SA, Odegard R, Skogvoll E, Wisloff U (2009) Aerobic interval training reduces cardiovascular risk factors more than a multitreatment approach in overweight adolescents. Clin Sci (Lond) 116(4):317–326. doi:10.1042/CS20080249 CrossRefGoogle Scholar
  29. 29.
    Simpson KA, Singh MA (2008) Effects of exercise on adiponectin: a systematic review. Obesity (Silver Spring) 16(2):241–256. doi:10.1038/oby.2007.53 CrossRefGoogle Scholar
  30. 30.
    Silva FM, de Almeida JC, Feoli AM (2011) Effect of diet on adiponectin levels in blood. Nutr Rev 69(10):599–612. doi:10.1111/j.1753-4887.2011.00414.x PubMedCrossRefGoogle Scholar
  31. 31.
    Murakami K, Sasaki S, Takahashi Y, Uenishi K, Yamasaki M, Hayabuchi H, Goda T, Oka J, Baba K, Ohki K, Watanabe R, Sugiyama Y (2007) Nutrient and food intake in relation to serum leptin concentration among young Japanese women. Nutrition 23(6):461–468. doi:10.1016/j.nut.2007.04.006 PubMedCrossRefGoogle Scholar
  32. 32.
    Santos S, Oliveira A, Lopes C (2013) Systematic review of saturated fatty acids on inflammation and circulating levels of adipokines. Nutr Res 33(9):687–695. doi:10.1016/j.nutres.2013.07.002 PubMedCrossRefGoogle Scholar
  33. 33.
    Kirel B, Dogruel N, Korkmaz U, Kilic FS, Ozdamar K, Ucar B (2000) Serum leptin levels in type 1 diabetic and obese children: relation to insulin levels. Clin Biochem 33(6):475–480PubMedCrossRefGoogle Scholar
  34. 34.
    Martos-Moreno GA, Barrios V, Soriano-Guillen L, Argente J (2006) Relationship between adiponectin levels, acylated ghrelin levels, and short-term body mass index changes in children with diabetes mellitus type 1 at diagnosis and after insulin therapy. Eur J Endocrinol 155(5):757–761. doi:10.1530/eje.1.02273 PubMedCrossRefGoogle Scholar
  35. 35.
    Hanaki K, Becker DJ, Arslanian SA (1999) Leptin before and after insulin therapy in children with new-onset type 1 diabetes. J Clin Endocrinol Metabolism 84(5):1524–1526Google Scholar
  36. 36.
    McCormick KL, Mick GJ, Butterfield L, Ross H, Parton E, Totka J (2001) Leptin in children with newly diagnosed type 1 diabetes: effect of insulin therapy. Int J Exp Diabetes Res 2(2):121–127PubMedCentralPubMedCrossRefGoogle Scholar
  37. 37.
    Barnes MM, Curran-Everett D, Hamman RF, Maahs D, Mayer-Davis EJ, D’Agostino RB Jr, West N, Dabelea D (2008) Determinants of adiponectin levels in young people with Type 1 diabetes. Diabet Med 25(3):365–369. doi:10.1111/j.1464-5491.2007.02374.x PubMedCrossRefGoogle Scholar
  38. 38.
    Abd El-Maksoud AM, El Hefnawy MH, Abdel-Ghaffar AR, Eskander EF, Ahmed HH, Seoudi DM, Yahya SM, Kamal IH (2009) Adiponectin, leptin, and lipid profile in type 1 diabetic children and adolescents. J Clin Lipidol 3(4):269–274. doi:10.1016/j.jacl.2009.07.002 PubMedCrossRefGoogle Scholar
  39. 39.
    Kratzsch J, Knerr I, Galler A, Kapellen T, Raile K, Korner A, Thiery J, Dotsch J, Kiess W (2006) Metabolic decompensation in children with type 1 diabetes mellitus associated with increased serum levels of the soluble leptin receptor. Eur J Endocrinol 155(4):609–614. doi:10.1530/eje.1.02261 PubMedCrossRefGoogle Scholar
  40. 40.
    Kaas A, Pfleger C, Hansen L, Buschard K, Schloot NC, Roep BO, Mortensen HB (2010) Association of adiponectin, interleukin (IL)-1ra, inducible protein 10, IL-6 and number of islet autoantibodies with progression patterns of type 1 diabetes the first year after diagnosis. Clin Exp Immunol 161(3):444–452. doi:10.1111/j.1365-2249.2010.04193.x PubMedCentralPubMedCrossRefGoogle Scholar
  41. 41.
    Bottner A, Kratzsch J, Muller G, Kapellen TM, Bluher S, Keller E, Bluher M, Kiess W (2004) Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J Clin Endocrinol Metab 89(8):4053–4061. doi:10.1210/jc.2004-0303 PubMedCrossRefGoogle Scholar
  42. 42.
    Svensson J, Lyngaae-Jorgensen A, Carstensen B, Simonsen LB, Mortensen HB (2009) Long-term trends in the incidence of type 1 diabetes in Denmark: the seasonal variation changes over time. Pediatr Diabetes 10(4):248–254. doi:10.1111/j.1399-5448.2008.00483.x PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2014

Authors and Affiliations

  • Narges Safai
    • 1
  • Stefanie Eising
    • 2
  • David Michael Hougaard
    • 3
  • Henrik Bindesbøl Mortensen
    • 4
  • Kristin Skogstrand
    • 3
  • Flemming Pociot
    • 4
  • Jesper Johannesen
    • 4
  • Jannet Svensson
    • 4
  1. 1.Steno Diabetes CenterGentofteDenmark
  2. 2.Hørup LægehusSydalsDenmark
  3. 3.Center for Neonatal Screening, Department of Clinical Biochemistry, Immunology and GeneticsStatens Serum InstitutCopenhagenDenmark
  4. 4.Herlev Hospital, Department of PediatricsUniversity of CopenhagenHerlevDenmark

Personalised recommendations